Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NaT-PROBEi zonisamide trial in at-risk Lewy body disease
jRCTs041190126Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Lewy body dementia (LBD), Parkinson's disease (PD) and dementia with Lewy bodies (DLB) comparing Zonisamide with Placebo (2 arms). Started Feb 2021; status: active, not recruiting.
02
Drugs
zonisamide
03
Conditions
Lewy body dementia (LBD)Parkinson's disease (PD)dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on jRCTs041190126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190126.